Development of a model based on body composition to predict drug kinetics: II. Application of the model to the use of digoxin in elderlies

Pharmacological Research

Volumn 50, Issue 1, 2004, Pages 105-108

  Ferrara, S ^a   Pazzucconi, F ^a   Bondioli, A ^a   Mombelli, G ^a   Agrati, A ^b   Ferraro, G ^b   Zoppi, F ^b   De Rosa, C ^b   Calabresi, L ^a   Sirtori, C R ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Body composition; Digoxin; Impedance method; Kinetic modeling

Indexed keywords

DIGOXIN;

AGED; ARTICLE; BIOENERGY; BLOOD SAMPLING; BODY COMPOSITION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNOCHEMISTRY; IMPEDANCE; KIDNEY FUNCTION TEST; LABORATORY TEST; MALE; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MEDICAL ASSESSMENT; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RELIABILITY; STATISTICAL SIGNIFICANCE;

AGED; BLOOD PRESSURE; BODY COMPOSITION; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; DIGOXIN; ELECTRIC IMPEDANCE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOCHEMISTRY; MALE; MODELS, BIOLOGICAL; PHARMACOKINETICS; RISK FACTORS;

EID: 11144356668     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phrs.2003.12.014     Document Type: Article

References (10)

1. Montamat S.C., Cusack B.J., Vestal R.E. Management of drug therapy in elderly. New Engl. J. Med. 321:1989;303-309.
2. Rowe J.W., Andres R., Tobin J.D., Norris A.H., Shock N.W. The effect of age on creatine clearance in men: a cross-sectional and longitudinal study. J. Gerontol. 31:1976;155-163.
3. Nolan L., O'Malley K. Prescribing for the elderly. Part II. Prescribing patterns: differences due to age. J. Am. Geriatr. Soc. 36:1988;245-254.
4. Wettrell G., Andersson K.E. Cardiovascular drugs II: digoxin. Ther. Drug Monit. 8:1986;129-139.
5. Lukaski H.C., Johnson P.E., Bolonchuk W.W., Lykken G.I. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am. J. Clin. Nutr. 41:1985;810-817.
6. Aronson J.K. Indications for the measurement of plasma digoxin concentrations. Drugs. 26:1983;230-242.
7. Hoffmeyer S., Burk O., von Richter O., Arnold H.P., Brockmöller J., Johne A.et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glucoprotein expression and in vivo. Proc. Natl. Acad. Sci. U.S.A. 97:2000;3473-3478.
8. Brainbridge A.D., Herlihy O., Meredith P.A., Elliot H.L. A comparative assessment of amlodipine and felodipine ER: pharmacokinetic and pharmacodynamic indices. Eur. J. Clin. Pharmacol. 45:1993;425-430.
9. Mangione A., Schentag J.J. Therapeutic monitoring of aminoglycoside antibiotics: an approach. Ther. Drug Monit. 2:1980;159-167.
10. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.